Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

High-Growth Stocks Come Back Into Investors' Favor

By Zacks Investment ResearchStock MarketsJun 23, 2021 07:12AM ET
www.investing.com/analysis/highgrowth-stocks-come-back-into-investors-favor-200587910
High-Growth Stocks Come Back Into Investors' Favor
By Zacks Investment Research   |  Jun 23, 2021 07:12AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
TSLA
-0.57%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SPLK
-3.37%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NVTA
-4.71%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SHOP
-0.94%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
TWLO
-1.69%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CRWD
-0.98%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Growth-heavy equities had been beaten down by the fear of rising interest rates in the face of inflationary pressures since mid-February but bottomed out in mid-May (remember, high-growth stocks are much more interest-rate sensitive than any other equity grouping). Investors are predicting what businesses will be running our rapidly digitalizing economy by the end of the Roaring 20s and have been placing their bets this past month.

Relatively discounted growth names are being bought up with vigor as they fall back into market favor. You can see this illustrated in the Ark Innovation ETF ARKK, which was up more than 2% today and has rallied 27% in less than 6 weeks of trading.

Cathie Wood Is Back in The Spotlight

Cathie Wood's Ark Innovation ETF (ARKK) was the most talked-about ETF of 2020, exhibiting a 360% return from its 2020 March lows to its mid-February 2021 highs. These returns were driven by the active ETF's penchant for "disruptive innovation," which is synonymous with extreme-growth stocks that have proven to be high-risk, high-reward. The 10 years of economic digitalization in 10 months amid the global lockdowns combined with ultra-low interest rates propelled Ark's growth-heavy holdings to the moon.

This ETF has become the high-growth tech index in the markets today. Its holdings include innovative market disruptors in numerous tech-powered spaces like the revolutionary EV start-up Tesla (NASDAQ:TSLA) TSLA (the most significant holding at 9.5%). Retail digitizers like Shopify (NYSE:SHOP) SHOP and Square (SQ). AI-powerhouses like Twilio (NYSE:TWLO) TWLO and UIPath PATH. DNA manipulators like CRISPR Therapeutics CRSP, 10x Genomics (NASDAQ:TXG) TXG, and Invitae (NYSE:NVTA), and so many other visionary enterprises that are poised to explode in the 4th Industrial Revolution.

Mid-February marked a narrative shift away from rich multiple growth names as the soaring US 10-Year yield instilled profit-pulling fear in tech. ARKK hit its peak on February 16th and troughed on May 13th for a 39% (nearly) 3-month decline, illustrating the risk of Cathie's high-multiple holdings in her innovative ETF. However, the short-term bottom for next-generation enterprises is in, and high multiple stocks are returning to investors' favor.

It may be prudent to consider either this ETF or some well-positioned growth-heavy tech names for a long-term investment. I believe that stocks of the future like CrowdStrike CRWD, Twilio TWLO, and Splunk (NASDAQ:SPLK) SPLK are going to be market drivers through the next decade.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Tesla, Inc. (TSLA): Free Stock Analysis Report

Splunk Inc. (SPLK): Free Stock Analysis Report

UiPath, Inc. (PATH): Free Stock Analysis Report

Shopify Inc. (SHOP): Free Stock Analysis Report

Twilio Inc. (TWLO): Free Stock Analysis Report

ARK Innovation ETF (ARKK): ETF Research Reports

CRISPR Therapeutics AG (CRSP): Free Stock Analysis Report

CrowdStrike Holdings Inc. (NASDAQ:CRWD): Free Stock Analysis Report

10x Genomics Inc. (TXG): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
High-Growth Stocks Come Back Into Investors' Favor
 

Related Articles

Declan Fallon
Markets Consolidate Gains By Declan Fallon - Dec 02, 2022

Thursday's action did me favor and ensured there was no significant give-back to Wednesday's gains. What was important (for me) was that gains managed to negate the lingering...

High-Growth Stocks Come Back Into Investors' Favor

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Danny Russo
Danny Russo Jul 01, 2021 3:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I absolutely love this research it's always on it.I'm
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email